APOC2 and hyperlipidemia: Our studies demonstrate that as early as at 3 dpf, apoc2 mutant larvae already display remarkable hyperlipidemia, and in 6 dpf embryos, dramatic differences in circulating neutral lipids were detected with ORO staining and confirmed with biochemical measurements of TG and TC levels in whole-body homogenates (Fig. 4).